Loading clinical trials...
Loading clinical trials...
OCS DCD Heart + CAP Continued Follow-Up Post-Approval Study
The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of California San Diago
La Jolla, California, United States
Stanford University
Palo Alto, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Mayo Clinic Florida
Jacksonville, Florida, United States
AdventHealth Orlando
Orlando, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
Northwestern Medicine
Chicago, Illinois, United States
St. Vincent Cardiovascular Research Institute
Indianapolis, Indiana, United States
Tufts Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
November 26, 2019
Primary Completion Date
October 1, 2026
Completion Date
October 1, 2026
Last Updated
September 9, 2025
276
ESTIMATED participants
OCS Heart
DEVICE
Lead Sponsor
TransMedics
NCT05732779
NCT07359690
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions